Home LiteratureArticle Details
PMID: 7565730 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.

Molecular and cellular biology ·Vol. 15 ·No. 10 ·1995-10-00 ·Pages 5770-6

Riese DJ, van Raaij TM, Plowman GD, Andrews GC, Stern DF

Abstract

Deregulated signaling by the four members of the epidermal growth factor receptor tyrosine kinase family (erbB family) is implicated in the genesis or progression of human cancers. However, efforts to analyze signaling by these receptors have been hampered by the diversity of ligands and extensive interreceptor cross talk. We have expressed the four human erbB family receptors, singly and in pairwise combinations, in a pro-B-lymphocyte cell line (Ba/F3) and investigated the range of interactions activated by the epidermal growth factor homology domain of the agonist neuregulin beta. The results provide the first comprehensive analysis of the response of this receptor family to a single peptide agonist. This peptide induced complex patterns of receptor tyrosine phosphorylation and regulation of Ba/F3 cell survival and proliferation. These data demonstrate the existence of several previously undocumented receptor interactions driven by neuregulin.

MeSH Terms
B-Lymphocytes Cell Count/drug effects Cell Line Cell Survival/drug effects Enzyme Activation ErbB Receptors/agonists,biosynthesis,genetics,metabolism Glycoproteins/chemical synthesis,pharmacology Humans Interleukin-3/pharmacology Neuregulins Peptides/chemical synthesis Phosphorylation Signal Transduction/drug effects
Chemicals
Glycoproteins Interleukin-3 Neuregulins Peptides ErbB Receptors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Riese D J
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.
van Raaij T M
Plowman G D
Andrews G C
Stern D F
References (54)
54 references, click to expand
  1. Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.
    J Virol. 1978 Dec;28(3):957-71 PMID: 215787
  2. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.
    Cell. 1985 Jul;41(3):727-34 PMID: 3924409
  3. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
    Science. 1987 Dec 4;238(4832):1408-10 PMID: 3500513
  4. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    EMBO J. 1988 Apr;7(4):995-1001 PMID: 3261240
  5. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
    EMBO J. 1988 Jun;7(6):1647-51 PMID: 2901952
  6. Transfer of functional EGF receptors to an IL3-dependent cell line.
    J Cell Physiol. 1988 Nov;137(2):293-8 PMID: 3263970
  7. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):9312-6 PMID: 3143116
  8. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
    Nature. 1990 Feb 22;343(6260):762-4 PMID: 2154701
  9. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling.
    Science. 1990 Apr 6;248(4951):79-83 PMID: 2181668
  10. Improved retroviral vectors for gene transfer and expression.
    Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 PMID: 2631796
  11. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Cell. 1990 Jun 29;61(7):1339-47 PMID: 1973074
  12. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.
    Proc Natl Acad Sci U S A. 1990 Jul;87(13):4905-9 PMID: 2164210
  13. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Science. 1990 Sep 28;249(4976):1552-5 PMID: 2218496
  14. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation.
    Biochemistry. 1990 Dec 18;29(50):11024-8 PMID: 1980216
  15. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.
    EMBO J. 1991 Apr;10(4):845-55 PMID: 1849073
  16. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene.
    Cancer Res. 1991 May 15;51(10):2593-8 PMID: 1673637
  17. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
    Cell. 1992 Apr 3;69(1):205-16 PMID: 1348215
  18. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.
    Cell. 1992 May 1;69(3):559-72 PMID: 1349853
  19. Identification of heregulin, a specific activator of p185erbB2.
    Science. 1992 May 22;256(5060):1205-10 PMID: 1350381
  20. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.
    Cell. 1992 Jul 10;70(1):57-67 PMID: 1535827
  21. Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists.
    J Biol Chem. 1992 Jul 25;267(21):15160-7 PMID: 1353079
  22. ARIA, a protein that stimulates acetylcholine receptor synthesis, also induces tyrosine phosphorylation of a 185-kDa muscle transmembrane protein.
    Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1624-8 PMID: 7679512
  23. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1746-50 PMID: 8383326
  24. Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.
    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1867-71 PMID: 8095334
  25. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family.
    Cell. 1993 Mar 12;72(5):801-15 PMID: 8453670
  26. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system.
    Nature. 1993 Mar 25;362(6418):312-8 PMID: 8096067
  27. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.
    EMBO J. 1993 Mar;12(3):961-71 PMID: 8096177
  28. Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types.
    Mol Cell Biol. 1993 Jun;13(6):3706-13 PMID: 8388543
  29. Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor.
    J Biol Chem. 1993 Sep 5;268(25):18407-10 PMID: 7689552
  30. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
    Nature. 1993 Dec 2;366(6454):473-5 PMID: 7902537
  31. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members.
    Mol Cell Biol. 1994 Jan;14(1):492-500 PMID: 8264617
  32. Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development.
    Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1064-8 PMID: 8302832
  33. Structural and functional aspects of the multiplicity of Neu differentiation factors.
    Mol Cell Biol. 1994 Mar;14(3):1909-19 PMID: 7509448
  34. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.
    Cancer Res. 1994 Mar 1;54(5):1367-73 PMID: 7907001
  35. Glial growth factor restricts mammalian neural crest stem cells to a glial fate.
    Cell. 1994 May 6;77(3):349-60 PMID: 7910115
  36. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    J Biol Chem. 1994 May 20;269(20):14661-5 PMID: 7514177
  37. The erbB3 gene product is a receptor for heregulin.
    J Biol Chem. 1994 May 13;269(19):14303-6 PMID: 8188716
  38. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.
    Mol Cell Biol. 1994 Jun;14(6):3550-8 PMID: 7515147
  39. Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera.
    EMBO J. 1994 Jun 15;13(12):2831-41 PMID: 8026468
  40. NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
    FEBS Lett. 1994 Jul 25;349(1):139-43 PMID: 8045292
  41. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
    Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8132-6 PMID: 8058768
  42. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.
    J Biol Chem. 1994 Oct 7;269(40):24747-55 PMID: 7929151
  43. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
    J Biol Chem. 1994 Oct 7;269(40):25226-33 PMID: 7929212
  44. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression.
    Nature. 1995 Jan 12;373(6510):158-61 PMID: 7816098
  45. The biology of erbB-2/neu/HER-2 and its role in cancer.
    Biochim Biophys Acta. 1994 Dec 30;1198(2-3):165-84 PMID: 7819273
  46. Differential expression of ARIA isoforms in the rat brain.
    Neuron. 1995 Jan;14(1):103-15 PMID: 7530017
  47. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds.
    J Clin Invest. 1995 Feb;95(2):842-51 PMID: 7860768
  48. Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms.
    J Biol Chem. 1995 Mar 3;270(9):4784-91 PMID: 7876251
  49. Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.
    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1431-5 PMID: 7877996
  50. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
    J Biol Chem. 1995 Mar 31;270(13):7111-6 PMID: 7535767
  51. The structural basis for the specificity of epidermal growth factor and heregulin binding.
    J Biol Chem. 1995 Apr 21;270(16):9585-9 PMID: 7721889
  52. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.
    Cancer Res. 1995 May 1;55(9):1946-55 PMID: 7728765
  53. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Mol Endocrinol. 1995 Jan;9(1):14-23 PMID: 7760847
  54. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.
    J Biol Chem. 1984 Jun 25;259(12):7755-60 PMID: 6330079
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1995-10-00
Pages
5770-6
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC230829
Subset
IM
Grants
NCI NIH HHS · CA-45708-06 · United States
NICHD NIH HHS · HD-07149 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com